Vodafone Idea prepared to raise tariff costs in front of Jio and Airtel

Vodafone Idea prepared to raise tariff costs in front of Jio and Airtel

Vodafone Idea (Vi) was the first telecom network to increment prepaid tariff costs in India back in December with Jio and Airtel following. Presently, as indicated by a report by Livemint, the telecom network is prepared to be the first to raise prepaid tariff costs once more. After the post-earnings call, Ravinder Takkar, CEO of Vodafone Idea said the current costs are unsustainable. “If you look at the current pricing, there is something wrong with it. We have said before that we would not shy away from hiking prices and we will be happy to be the first one to do so. We hope others in the industry will follow,” Takkar noted.

As of now, Jio is leading the telecom sector with around 400 million clients, on account of its focus on adding new subscribers. While Airtel is focusing on expanding ARPU and income, it would seem that Vodafone Idea otherwise known as Vi may likewise employ a comparable procedure. Ravinder Takkar said the industry can’t continue at the current ARPU and it should be looking at Rs 300 ARPU over the long run. Bharti Airtel CEO, Gopal Vittal reiterated the equivalent and stated, “industry cannot continue to function at the current prices for voice and data services.”

While it isn’t clear when Vodafone Idea and Airtel will hike their prepaid tariff costs, everyone feels it could be around the bend considering the telcos raised the tariffs around a similar time a year back. Also, there are reports that TRAI may soon set a story cost for voice and information in the nation soon. Notwithstanding, there’s no timetable for the equivalent again except for is on the priority if bits of gossip are to be accepted.

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Bengaluru Bytes journalist was involved in the writing and production of this article.

Topics #Airtel #Jio #Ravinder Takkar #Vodafone Idea